Literature DB >> 4271305

Clinical experience with adverse reactions to trimethoprim-sulfamethoxazole.

J M Frisch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4271305     DOI： 10.1093/infdis/128.supplement_3.s607

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  14 in total

Review 1.  Disseminated Pneumocystis carinii in a patient receiving aerosolized pentamidine prophylaxis.

Authors:  S M Berman; B Shah; F A Wyle; M Dacosta-Iyer; D M McRae
Journal:  West J Med       Date:  1990-07

2.  Hepatic cholestasis induced by trimethoprim.

Authors:  A R Tanner
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

3.  Comparison of sulfamethoxazole alone and combined with trimethoprim in urinary tract infections.

Authors:  T Bergan; O Skjerven
Journal:  Infection       Date:  1979       Impact factor: 3.553

4.  Pharmacokinetics of trimethoprim-sulfamethoxazole in children.

Authors:  C M Wilfert; L T Gutman
Journal:  Can Med Assoc J       Date:  1975-06-14       Impact factor: 8.262

Review 5.  Cotrimoxazole. Rationale for re-examining its indications for use.

Authors:  R A Howe; R C Spencer
Journal:  Drug Saf       Date:  1996-04       Impact factor: 5.606

6.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

7.  Trends in adverse reactions to trimethoprim-sulfamethoxazole.

Authors:  Jennifer L Goldman; Mary Anne Jackson; Joshua C Herigon; Adam L Hersh; Daniel J Shapiro; J Steven Leeder
Journal:  Pediatrics       Date:  2012-12-03       Impact factor: 7.124

8.  Treatment of seven cases of chronic granulomatous disease with sulfamethoxazole-trimethoprim (SMX-TMP).

Authors:  Y Kobayashi; D Amano; K Ueda; Y Kagosaki; T Usui
Journal:  Eur J Pediatr       Date:  1978-04-20       Impact factor: 3.183

9.  Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole), pyrimethamine-sulphadiazine and spiramycin during avirulent infection with Toxoplasma gondii (Beverley strain) in mice.

Authors:  B T Nguyen; S Stadtsbaeder
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

10.  Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole) and spiramycin in pregnant mice infected with Toxoplasma gondii (Beverley strain).

Authors:  B T Nguyen; S Stadtsbaeder
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.